Cashman Christopher Michael 4/A
4/A · MARINUS PHARMACEUTICALS INC · Filed Jan 22, 2018
Insider Transaction Report
Form 4/AAmended
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Award
Common stock
2017-01-17+60,600→ 257,469 total
Footnotes (1)
- [F1]Represents restricted common stock. 20,200 shares of restricted common stock each vest on 1/17/18, 1/17/19, and 1/17/20, respectively. This amendment is being filed to correct the reporting of restricted stock grants moving the report of grant of the restricted stock from Table II to Table I of the report being amended.